Cortisol effects of D-amphetamine relate to traits of fearlessness and aggression but not anxiety in healthy humans

被引:16
|
作者
White, Tara L.
Grover, Vandana K.
de Wit, Harriet
机构
[1] Brown Univ, Dept Psychiat & Human Behav, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
[2] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA
关键词
sensation seeking; positive affect; human; individual differences; norepinephrine; dopamine; trait fearlessness; trait anxiety;
D O I
10.1016/j.pbb.2006.07.020
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The current study utilized personality measures thought to relate to noradrenergic and catecholamine function (i.e., sensation seeking, anxiety and aggression) to investigate individual differences in amphetamine-induced increases in cortisol. The goal of the study was to better understand variations in responses to psychostimulants in healthy volunteers. Method: A placebo-controlled within-subjects investigation of salivary cortisol responses to oral D-amphetamine (20 mg) was conducted in seventy (N=70) young adults. Personality traits were assessed using the Eysenck Personality Inventory (EPI), Sensation Seeking Scale Form V (SSS-V) and the Multidimensional Personality Questionnaire-Brief Form (MPQ-BF). Results: A more rapid rise in salivary cortisol after D-amphetamine was associated with SSS-V Thrill Seeking (r=-0.32 with time to peak, p < 0.05). A greater peak increase in cortisol and a greater recovery after amphetamine was positively associated with MPQ-BF Aggression (r=+0.35, p < 0.05; r=+0.38, p < 0.05). In contrast, cortisol responses were unrelated to a composite measure of trait anxiety (EPI/MPQ-BF Anxiety Index). Conclusions: The findings suggest that the personality traits of aggression and thrill seeking are related to cortisol responses to D-amphetamine, raising the possibility that personality may predispose certain individuals to use drugs through a glucocorticoid pathway. The data also suggest a distinction between fear and anxiety, as amphetamine-induced cortisol responses were associated with measures of trait fear but not measures of trait anxiety in the current sample. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 50 条
  • [1] EFFECTS OF D-AMPHETAMINE ON SPEAKING IN ISOLATED HUMANS
    STITZER, ML
    GRIFFITHS, RR
    LIEBSON, I
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1978, 9 (01) : 57 - 63
  • [2] CONTRASTING EFFECTS OF D-AMPHETAMINE ON AFFILIATION AND AGGRESSION IN MONKEYS
    SMITH, EO
    BYRD, LD
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 20 (02) : 255 - 260
  • [3] INTRASPECIES AGGRESSION IN RATS - EFFECTS OF D-AMPHETAMINE AND CHLORDIAZEPOXIDE
    MICZEK, KA
    PSYCHOPHARMACOLOGIA, 1974, 39 (04): : 275 - 301
  • [4] Enhanced behavioral response to repeated d-amphetamine and personality traits in humans
    Sax, KW
    Strakowski, SM
    BIOLOGICAL PSYCHIATRY, 1998, 44 (11) : 1192 - 1195
  • [5] Subjective and behavioral effects of repeated d-amphetamine in humans
    Wachtel, SR
    de Wit, H
    BEHAVIOURAL PHARMACOLOGY, 1999, 10 (03): : 271 - 281
  • [6] Alprazolam attenuates the behavioral effects of D-amphetamine in humans
    Rush, CR
    Stoops, WW
    Wagner, FP
    Hays, LR
    Glaser, PEA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (04) : 410 - 420
  • [7] Effects of d-amphetamine in grouped versus isolated humans
    deWit, H
    Clark, M
    Brauer, LH
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (1-2) : 333 - 340
  • [8] THE DISCRIMINATIVE STIMULUS AND SUBJECTIVE EFFECTS OF D-AMPHETAMINE IN HUMANS
    CHAIT, LD
    UHLENHUTH, EH
    JOHANSON, CE
    PSYCHOPHARMACOLOGY, 1985, 86 (03) : 307 - 312
  • [9] Personality and the acute subjective effects of d-amphetamine in humans
    Kirkpatrick, Matthew G.
    Johanson, Chris-Ellyn
    de Wit, Harriet
    JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (03) : 256 - 264
  • [10] Riluzole and D-amphetamine interactions in humans
    Sofuoglu, Mehmet
    Waters, Andrew J.
    Mooney, Marc
    Kosten, Thomas
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01): : 16 - 22